1.46
Schlusskurs vom Vortag:
$1.46
Offen:
$1.45
24-Stunden-Volumen:
1.77M
Relative Volume:
0.41
Marktkapitalisierung:
$231.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-110.78M
KGV:
-1.3645
EPS:
-1.07
Netto-Cashflow:
$-75.59M
1W Leistung:
-7.59%
1M Leistung:
-35.40%
6M Leistung:
-54.38%
1J Leistung:
-74.34%
Humacyte Inc Stock (HUMA) Company Profile
Firmenname
Humacyte Inc
Sektor
Branche
Telefon
919-313-9633
Adresse
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Vergleichen Sie HUMA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
HUMA
Humacyte Inc
|
1.46 | 239.14M | 0 | -110.78M | -75.59M | -1.07 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-27 | Eingeleitet | Barclays | Overweight |
2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
2024-12-20 | Bestätigt | H.C. Wainwright | Buy |
2023-12-11 | Eingeleitet | H.C. Wainwright | Buy |
2023-08-14 | Hochstufung | Piper Sandler | Underweight → Neutral |
2023-06-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
2022-05-16 | Herabstufung | Piper Sandler | Overweight → Underweight |
2021-10-29 | Eingeleitet | Cowen | Outperform |
2021-09-24 | Eingeleitet | Oppenheimer | Outperform |
2021-09-22 | Eingeleitet | BTIG Research | Buy |
2021-09-16 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Humacyte Inc Aktie (HUMA) Neueste Nachrichten
What’s the recovery path for long term holders of Humacyte Inc.CPI Data & Risk Controlled Swing Trade Alerts - Newser
Sector ETF performance correlation with Humacyte Inc. Equity WarrantJuly 2025 EndofMonth & Accurate Entry/Exit Alerts - Newser
Is a relief rally coming for Humacyte Inc. holders2025 Geopolitical Influence & Expert-Curated Trade Recommendations - Newser
Published on: 2025-09-03 06:28:25 - Newser
Can swing trading help recover from Humacyte Inc. losses2025 Valuation Update & Fast Exit and Entry Trade Guides - Newser
How to forecast Humacyte Inc. Equity Warrant trends using time seriesPortfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Custom watchlist performance reports with Humacyte Inc. Equity Warrant2025 Key Lessons & Daily Volume Surge Trade Alerts - Newser
How to manage a losing position in Humacyte Inc. Equity WarrantEarnings Summary Report & Community Trade Idea Sharing - Newser
Using Python tools to backtest Humacyte Inc. strategiesQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
What data driven models say about Humacyte Inc.’s futureChart Signals & Long-Term Investment Growth Plans - Newser
Will Humacyte Inc. benefit from macro trends2025 Big Picture & Breakout Confirmation Trade Signals - Newser
Full technical analysis of Humacyte Inc. stockMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
Humacyte Inc. Equity Warrant stock momentum explained2025 Pullback Review & Stock Portfolio Risk Management - Newser
Visualizing Humacyte Inc. Equity Warrant stock with heatmaps2025 Dividend Review & Community Consensus Trade Signals - Newser
Published on: 2025-09-03 02:22:53 - Newser
Should you wait for a breakout in Humacyte Inc.Risk Management & Daily Entry Point Alerts - Newser
Strategies to average down on Humacyte Inc. Equity Warrant2025 EndofYear Setup & Trade Opportunity Analysis - Newser
Is Humacyte Inc. Equity Warrant forming a reversal patternQuarterly Market Summary & Weekly Chart Analysis and Trade Guides - Newser
Real time social sentiment graph for Humacyte Inc. Equity WarrantJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
Price momentum metrics for Humacyte Inc. explainedJuly 2025 Technicals & Low Risk Entry Point Guides - Newser
Humacyte Inc. stock chart pattern explainedJuly 2025 News Drivers & Safe Entry Trade Signal Reports - Newser
What data driven models say about Humacyte Inc. Equity Warrant’s futureJuly 2025 Trends & Momentum Based Trading Ideas - Newser
What technical models suggest about Humacyte Inc.’s comebackJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
Can Humacyte Inc. Equity Warrant disrupt its industryProfit Target & Fast Momentum Stock Entry Tips - khodrobank.com
What machine learning models say about Humacyte Inc. Equity Warrant2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser
What MACD signals say about Humacyte Inc. Equity WarrantJuly 2025 Trade Ideas & Daily Market Momentum Tracking - Newser
Can swing trading help recover from Humacyte Inc. Equity Warrant lossesMarket Risk Analysis & Real-Time Volume Trigger Notifications - Newser
Will Humacyte Inc. outperform during market rallies2025 Macro Impact & Safe Swing Trade Setup Alerts - khodrobank.com
Is Humacyte Inc. Equity Warrant in a bullish channelWall Street Watch & Comprehensive Market Scan Reports - khodrobank.com
Price momentum metrics for Humacyte Inc. Equity Warrant explainedEarnings Recap Report & Advanced Swing Trade Entry Alerts - Newser
Will a bounce in Humacyte Inc. Equity Warrant offer an exitJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - Newser
Profit Recap: Is Humacyte Inc. in a consolidation phase2025 Trading Volume Trends & Weekly Chart Analysis and Guides - khodrobank.com
How sentiment analysis helps forecast Humacyte Inc.Share Buyback & Community Consensus Trade Alerts - Newser
Comparing Humacyte Inc. Equity Warrant in custom built stock radarsBreakout Watch & Precise Swing Trade Entry Alerts - Newser
Humacyte Inc.’s volatility index tracking explainedBuy Signal & Fast Entry Momentum Alerts - Newser
Humacyte Inc. stock momentum explainedPortfolio Gains Report & Weekly Market Pulse Alerts - Newser
Chart based analysis of Humacyte Inc. trends2025 Sector Review & Proven Capital Preservation Methods - Newser
Does Humacyte Inc. stock have upside surprise potentialTake Profit & Weekly Stock Performance Updates - khodrobank.com
Applying Wyckoff theory to Humacyte Inc. stockQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - Newser
Humacyte Inc. Equity Warrant stock prediction for this weekMarket Performance Recap & Safe Entry Momentum Tips - Newser
Is Humacyte Inc. Equity Warrant stock heavily shorted2025 Earnings Impact & Weekly Watchlist for Consistent Profits - khodrobank.com
Fed Watch: Is Humacyte Inc. a speculative investmentTrend Reversal & Target Return Focused Picks - khodrobank.com
Order flow analysis tools used on Humacyte Inc. Equity WarrantQuarterly Trade Review & Accurate Trade Setup Notifications - Newser
Using Bollinger Bands to evaluate Humacyte Inc.Dividend Hike & Real-Time Stock Entry Alerts - Newser
Finanzdaten der Humacyte Inc-Aktie (HUMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Humacyte Inc-Aktie (HUMA) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Dougan Brady W | Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
Dougan Brady W | Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
Niklason Laura E | President, CEO and Director |
Aug 19 '25 |
Sale |
1.63 |
1,100,000 |
1,793,000 |
591,685 |
Niklason Laura E | President, CEO and Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
Niklason Laura E | President, CEO and Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):